Literature DB >> 9844109

Bone mass in middle-aged osteoporotic men and their relatives: familial effect.

M E Cohen-Solal1, C Baudoin, M Omouri, D Kuntz, M C De Vernejoul.   

Abstract

Severe idiopathic osteoporosis in middle-aged men is still poorly understood. The aim of this study was to assess the contribution of genetic factors in these patients. We studied 38 men (mean age +/- SD, 50 +/- 11 years) presenting with vertebral or peripheral bone fractures due to primary osteoporosis and 73 of their relatives divided into four subgroups: 19 brothers, 22 sisters, 13 sons, and 19 daughters. The control group comprised 199 age-matched subjects. In all subjects, we measured bone mineral density (BMD) and calculated the Z score at the lumbar spine (LS) and femoral neck (FN) based on the fitted BMD value in the controls. LS BMD values were lower in each of the four subgroups compared with the age-matched controls. The mean Z score for the overall group of 73 relatives was decreased compared with the age-matched controls (-1. 28 +/- 1.48 at the LS and -1.03 +/- 1.19 at the FN) and was not influenced by gender or by whether the relatives were siblings or children. An LS Z score < -1) was found in 54.8% of the relatives of osteoporotic patients versus 17.4% of the control subjects (risk ratio, 3.2). Alcohol and tobacco abuse are well-known risk factors for osteoporosis in men. Among the 38 osteoporotic patients, 7 were heavy smokers (>20 pack-years), 8 were both heavy smokers and drinkers (>80 g/day for at least 10 years and gammaGT > 40 UI/l), and 23 had neither of these risk factors. BMD, Z score, and anthropometric data were the same in patients with and without risk factors. Decreases in LS and FN Z scores were similar in relatives of patients with and without risk factors. In conclusion, low BMD is observed in relatives of osteoporotic men with or without risk factors for osteoporosis, indicating that familial factors contribute to primary osteoporosis in middle-aged men.

Entities:  

Mesh:

Year:  1998        PMID: 9844109     DOI: 10.1359/jbmr.1998.13.12.1909

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  9 in total

1.  Heterogeneity of biological bone markers in idiopathic male osteoporosis.

Authors:  Michel Laroche
Journal:  Rheumatol Int       Date:  2011-04-17       Impact factor: 2.631

Review 2.  Idiopathic osteoporosis in men.

Authors:  Luigi Gennari; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

3.  Pattern of bone mineral density in idiopathic male osteoporosis.

Authors:  Michel Laroche
Journal:  Rheumatol Int       Date:  2011-09-15       Impact factor: 2.631

Review 4.  Unresolved issues in osteoporosis in men.

Authors:  E Seeman
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 5.  Estrogen, androgen, and the pathogenesis of bone fragility in women and men.

Authors:  Ego Seeman
Journal:  Curr Osteoporos Rep       Date:  2004-09       Impact factor: 5.096

6.  Lean mass plays a gender-specific role in familial resemblance for femoral neck bone mineral density in adult subjects.

Authors:  H Blain; A Vuillemin; C Jeandel; P Jouanny; F Guillemin; E Le Bihan
Journal:  Osteoporos Int       Date:  2006-03-23       Impact factor: 4.507

Review 7.  The clinical epidemiology of male osteoporosis: a review of the recent literature.

Authors:  Tina Willson; Scott D Nelson; Jonathan Newbold; Richard E Nelson; Joanne LaFleur
Journal:  Clin Epidemiol       Date:  2015-01-09       Impact factor: 4.790

8.  Bone Mineral Density Is Negatively Associated With Arterial Stiffness in Men With Hypertension.

Authors:  Xue-Song Li; Hui He; Yi-Lin Zhao; Ying Li; Zhi-Ping Liu; Tiemin Liu; Yong Zhang; Kai-Jiang Yu; Rui-Tao Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-03       Impact factor: 3.738

Review 9.  Osteoporosis in men.

Authors:  Jennifer S Walsh; Richard Eastell
Journal:  Nat Rev Endocrinol       Date:  2013-09-10       Impact factor: 43.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.